Cite
MLA Citation
Aude de Gassart et al.. “442 ICT01, an anti-BTN3A mAb that activates Vg9Vd2 T cells, plus interleukin-2: a potent and promising combination for cancer immunotherapy.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A468. http://access.bl.uk/ark:/81055/vdc_100144710219.0x00000b